GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (NAS:AXGN) » Definitions » Cyclically Adjusted PB Ratio

Axogen (Axogen) Cyclically Adjusted PB Ratio : 3.22 (As of May. 28, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Axogen Cyclically Adjusted PB Ratio?

As of today (2024-05-28), Axogen's current share price is $6.70. Axogen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.08. Axogen's Cyclically Adjusted PB Ratio for today is 3.22.

The historical rank and industry rank for Axogen's Cyclically Adjusted PB Ratio or its related term are showing as below:

AXGN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.93   Med: 13.28   Max: 160.47
Current: 3.02

During the past years, Axogen's highest Cyclically Adjusted PB Ratio was 160.47. The lowest was 1.93. And the median was 13.28.

AXGN's Cyclically Adjusted PB Ratio is ranked worse than
64.12% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs AXGN: 3.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Axogen's adjusted book value per share data for the three months ended in Mar. 2024 was $2.132. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Axogen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Axogen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Cyclically Adjusted PB Ratio Chart

Axogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.20 15.19 6.96 6.01 3.45

Axogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 4.89 2.59 3.45 3.89

Competitive Comparison of Axogen's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Axogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Axogen's Cyclically Adjusted PB Ratio falls into.



Axogen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Axogen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6.70/2.08
=3.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Axogen's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.132/131.7762*131.7762
=2.132

Current CPI (Mar. 2024) = 131.7762.

Axogen Quarterly Data

Book Value per Share CPI Adj_Book
201406 -0.411 100.560 -0.539
201409 -0.583 100.428 -0.765
201412 -0.577 99.070 -0.767
201503 -0.027 99.621 -0.036
201506 -0.142 100.684 -0.186
201509 0.374 100.392 0.491
201512 0.273 99.792 0.360
201603 0.161 100.470 0.211
201606 0.093 101.688 0.121
201609 0.037 101.861 0.048
201612 0.452 101.863 0.585
201703 0.367 102.862 0.470
201706 0.341 103.349 0.435
201709 0.316 104.136 0.400
201712 0.733 104.011 0.929
201803 0.626 105.290 0.783
201806 3.928 106.317 4.869
201809 3.865 106.507 4.782
201812 3.778 105.998 4.697
201903 3.597 107.251 4.420
201906 3.515 108.070 4.286
201909 3.431 108.329 4.174
201912 3.338 108.420 4.057
202003 3.125 108.902 3.781
202006 2.992 108.767 3.625
202009 3.033 109.815 3.640
202012 3.032 109.897 3.636
202103 2.931 111.754 3.456
202106 2.872 114.631 3.302
202109 2.774 115.734 3.159
202112 2.697 117.630 3.021
202203 2.474 121.301 2.688
202206 2.413 125.017 2.543
202209 2.400 125.227 2.526
202212 2.379 125.222 2.504
202303 2.278 127.348 2.357
202306 2.260 128.729 2.314
202309 2.273 129.860 2.307
202312 2.218 129.419 2.258
202403 2.132 131.776 2.132

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Axogen  (NAS:AXGN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Axogen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Axogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Axogen (Axogen) Business Description

Traded in Other Exchanges
Address
13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Executives
Peter J Mariani officer: Chief Financial Officer C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Amy Mcbride Wendell director COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Burke William P. Mr. director HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Guido J Neels director C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Gregory Gene Freitag director 13631 PROGRESS BLVD., ALACHUA FL 32615
Marc A Began officer: EVP & General Counsel C/O ABIOMED, INC., 22 CHERRY HILL DRIVE, DANVERS MA 01923
Joseph A. Tyndall director 13631 PROGRESS BLVD., SUITE 400, ALACHUA FL 32615
John Johnson director DENDREON CORPORATION, 1301 2ND AVENUE, SEATTLE WA 98101
Karen L. Zaderej director, officer: CEO AXOGEN INC., 13859 PROGRESS BLVD, SUITE 100, ALACHUA FL 32615
Michael Patrick Donovan officer: VP Operations C/O AXOGEN, INC., 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL 32615
Maria D. Martinez officer: Chief Human Resources Officer C/O AXOGEN INC., 13631 PROGRESS BLVD, SUITE 400, ALACHUA FL 32615
Paul Thomas director ONE MILLENNIUM WAY, BRANCHBURG NJ 08876
Alan M Levine director C/O AXOGEN, INC., 13631 PROGRESS BLVD. - SUITE 400, ALACHUA FL 32615
Mark Stephen Gold director 13859 PROGRESS BLVD SUITE 100, ALACHUA FL 32615
Quentin S. Blackford director 7475 LUSK BLVD., SAN DIEGO CA 92121